A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial.
作者:
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);队列研究(Cohort Studies);阿糖胞苷(Cytarabine);柔红霉素(Daunorubicin);无病生存(Disease-Free Survival);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);男(雄)性(Male);中年人(Middle Aged);多元分析(Multivariate Analysis);核蛋白质类(Nuclear Proteins);预后(Prognosis);比例危险度模型(Proportional Hazards Models);前瞻性研究(Prospective Studies);缓解诱导(Remission Induction);危险因素(Risk Factors);fms样酪氨酸激酶3(fms-Like Tyrosine Kinase 3)
DOI
10.1182/blood-2010-01-267302
PMID
20442365
发布时间
2022-04-11
- 浏览14

Blood
971-8页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文